Pharmacyclics, Inc. (PCYC) Blows Up Q2 Views, Posts Surprise Profit

Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of $0.82, $1.00 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $77.9 million versus the consensus estimate of $2.64 million.

For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Honeywell Technologies revises 2026 EPS guidance after stock split
• AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance